Wave Life Sciences (WVE) Competitors $6.24 +0.24 (+4.00%) As of 02:28 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock WVE vs. RYTM, PTCT, OGN, ZLAB, ACLX, RNA, RARE, AKRO, MOR, and SWTXShould you be buying Wave Life Sciences stock or one of its competitors? The main competitors of Wave Life Sciences include Rhythm Pharmaceuticals (RYTM), PTC Therapeutics (PTCT), Organon & Co. (OGN), Zai Lab (ZLAB), Arcellx (ACLX), Avidity Biosciences (RNA), Ultragenyx Pharmaceutical (RARE), Akero Therapeutics (AKRO), MorphoSys (MOR), and SpringWorks Therapeutics (SWTX). These companies are all part of the "pharmaceutical products" industry. Wave Life Sciences vs. Rhythm Pharmaceuticals PTC Therapeutics Organon & Co. Zai Lab Arcellx Avidity Biosciences Ultragenyx Pharmaceutical Akero Therapeutics MorphoSys SpringWorks Therapeutics Wave Life Sciences (NASDAQ:WVE) and Rhythm Pharmaceuticals (NASDAQ:RYTM) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, community ranking, dividends, media sentiment and earnings. Does the MarketBeat Community favor WVE or RYTM? Wave Life Sciences received 58 more outperform votes than Rhythm Pharmaceuticals when rated by MarketBeat users. However, 68.06% of users gave Rhythm Pharmaceuticals an outperform vote while only 67.84% of users gave Wave Life Sciences an outperform vote. CompanyUnderperformOutperformWave Life SciencesOutperform Votes36767.84% Underperform Votes17432.16% Rhythm PharmaceuticalsOutperform Votes30968.06% Underperform Votes14531.94% Which has more risk and volatility, WVE or RYTM? Wave Life Sciences has a beta of -0.93, indicating that its stock price is 193% less volatile than the S&P 500. Comparatively, Rhythm Pharmaceuticals has a beta of 2.32, indicating that its stock price is 132% more volatile than the S&P 500. Is WVE or RYTM more profitable? Wave Life Sciences has a net margin of -66.50% compared to Rhythm Pharmaceuticals' net margin of -230.07%. Wave Life Sciences' return on equity of -280.57% beat Rhythm Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Wave Life Sciences-66.50% -280.57% -52.90% Rhythm Pharmaceuticals -230.07%-367.36%-77.47% Do analysts recommend WVE or RYTM? Wave Life Sciences currently has a consensus target price of $22.18, suggesting a potential upside of 255.48%. Rhythm Pharmaceuticals has a consensus target price of $74.92, suggesting a potential upside of 21.49%. Given Wave Life Sciences' higher probable upside, equities research analysts plainly believe Wave Life Sciences is more favorable than Rhythm Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Wave Life Sciences 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 3.00Rhythm Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable valuation and earnings, WVE or RYTM? Wave Life Sciences has higher earnings, but lower revenue than Rhythm Pharmaceuticals. Rhythm Pharmaceuticals is trading at a lower price-to-earnings ratio than Wave Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWave Life Sciences$108.30M8.84-$57.51M-$0.79-7.90Rhythm Pharmaceuticals$130.13M29.96-$184.68M-$4.35-14.18 Do institutionals & insiders have more ownership in WVE or RYTM? 89.7% of Wave Life Sciences shares are owned by institutional investors. 29.1% of Wave Life Sciences shares are owned by insiders. Comparatively, 5.6% of Rhythm Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media favor WVE or RYTM? In the previous week, Rhythm Pharmaceuticals had 11 more articles in the media than Wave Life Sciences. MarketBeat recorded 29 mentions for Rhythm Pharmaceuticals and 18 mentions for Wave Life Sciences. Wave Life Sciences' average media sentiment score of 0.80 beat Rhythm Pharmaceuticals' score of 0.60 indicating that Wave Life Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Wave Life Sciences 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Rhythm Pharmaceuticals 13 Very Positive mention(s) 3 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryWave Life Sciences beats Rhythm Pharmaceuticals on 12 of the 18 factors compared between the two stocks. Remove Ads Get Wave Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WVE vs. The Competition Export to ExcelMetricWave Life SciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$957.75M$6.31B$5.32B$7.56BDividend YieldN/A3.23%5.11%4.33%P/E Ratio-5.626.7821.7717.81Price / Sales8.84222.80378.2693.59Price / CashN/A65.6738.1534.64Price / Book15.605.826.443.99Net Income-$57.51M$141.86M$3.20B$247.23M7 Day Performance11.43%8.99%6.42%7.24%1 Month Performance-38.94%-12.57%-8.66%-6.26%1 Year Performance8.71%-12.38%10.27%-0.18% Wave Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WVEWave Life Sciences4.1811 of 5 stars$6.24+4.0%$22.18+255.5%+3.4%$957.75M$108.30M-5.62240Short Interest ↑Analyst RevisionRYTMRhythm Pharmaceuticals3.7001 of 5 stars$54.96+17.1%$73.31+33.4%+49.1%$3.47B$130.13M-12.69140High Trading VolumePTCTPTC Therapeutics3.8947 of 5 stars$42.82-1.0%$63.77+48.9%+70.6%$3.38B$806.78M-7.211,410Short Interest ↑Positive NewsOGNOrganon & Co.4.7612 of 5 stars$12.54-3.9%$20.80+65.9%-35.3%$3.23B$6.40B3.7610,000Short Interest ↓ZLABZai Lab2.4857 of 5 stars$28.81-9.3%$47.37+64.4%+120.3%$3.16B$398.99M-10.401,950News CoverageGap DownHigh Trading VolumeACLXArcellx1.9765 of 5 stars$56.65-3.3%$110.67+95.4%+3.8%$3.11B$107.94M-79.7980News CoveragePositive NewsHigh Trading VolumeRNAAvidity Biosciences2.2741 of 5 stars$25.48-4.1%$66.69+161.7%+11.7%$3.06B$10.90M-8.85190Positive NewsRAREUltragenyx Pharmaceutical4.5611 of 5 stars$32.14-0.9%$92.79+188.7%-25.7%$3.02B$560.23M-5.071,310Positive NewsAKROAkero Therapeutics4.3073 of 5 stars$35.97-2.1%$76.29+112.1%+69.5%$2.86BN/A-9.5930Gap DownHigh Trading VolumeMORMorphoSysN/A$18.96flatN/AN/A$2.86B$238.28M-5.45730SWTXSpringWorks Therapeutics2.0536 of 5 stars$36.99-5.4%$73.20+97.9%-12.4%$2.77B$191.59M-10.63230Positive NewsHigh Trading Volume Remove Ads Related Companies and Tools Related Companies RYTM Alternatives PTCT Alternatives OGN Alternatives ZLAB Alternatives ACLX Alternatives RNA Alternatives RARE Alternatives AKRO Alternatives MOR Alternatives SWTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:WVE) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredFmr. Presidential Advisor’s Urgent Warning: “Exit Tech Now!”A former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Wave Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Wave Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy WVE Stock Free WVE Stock Alerts